Novel Technologies for Vaccine Development
(Sprache: Englisch)
This book presents a detailed overview of the development of new viral vector-based vaccines before discussing two major applications: preventive vaccines for infectious diseases and therapeutic cancer vaccines. Viral vector-based vaccines hold a great...
Leider schon ausverkauft
versandkostenfrei
Buch (Gebunden)
160.49 €
80 DeutschlandCard Punkte
sammeln
- Lastschrift, Kreditkarte, Paypal, Rechnung
- Kostenlose Rücksendung
- Ratenzahlung möglich
Produktdetails
Produktinformationen zu „Novel Technologies for Vaccine Development “
Klappentext zu „Novel Technologies for Vaccine Development “
This book presents a detailed overview of the development of new viral vector-based vaccines before discussing two major applications: preventive vaccines for infectious diseases and therapeutic cancer vaccines. Viral vector-based vaccines hold a great potential for development into successful pharmaceutical products and several examples at the advanced pre-clinical or clinical stage are presented. Nevertheless, the most efforts were focused on novel and very innovative technologies for new generation of vector-based vaccines. Furthermore, specific topics such as delivery and adjuvant and protection strategies for cell-mediated-based vaccines are presented. Given its scope, the book is a "must read" for all those involved in vaccine development, both in academia and industrial vaccine development.
Inhaltsverzeichnis zu „Novel Technologies for Vaccine Development “
TBD¿
Bibliographische Angaben
- 2015, 2014, XIV, 386 Seiten, 50 farbige Abbildungen, Maße: 16 x 24,1 cm, Gebunden, Englisch
- Herausgegeben: Igor S. Lukashevich, Haval Shirwan
- Verlag: Springer Wien
- ISBN-10: 3709118174
- ISBN-13: 9783709118177
Sprache:
Englisch
Kommentar zu "Novel Technologies for Vaccine Development"
0 Gebrauchte Artikel zu „Novel Technologies for Vaccine Development“
| Zustand | Preis | Porto | Zahlung | Verkäufer | Rating |
|---|
Schreiben Sie einen Kommentar zu "Novel Technologies for Vaccine Development".
Kommentar verfassen